Moderator note: Great discussion, everyone. Just a reminder to keep things civil and evidence-based.
Thread quality is excellent — keep it up. 👍
Slightly tangential to P2P payment apps but Dr.KarenChen reminded me — has the insurance landscape changed recently?
I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.
marcus_mpls said:Follow-up question: what labs did your doctor order to monitor this
This is exactly right. marcus_mpls articulated what I have been trying to explain to my friends for months. The P2P payment apps aspect is what made the difference for me.
Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.
Shop Reference StandardsSaving this for reference. Quality thread.
Adding my data to this P2P payment apps discussion:
| Metric | Baseline | Month 4 | Month 6 |
|---|---|---|---|
| Weight | 240 lbs | 245 lbs | 205 lbs |
| A1C | 6.4% | 6.2% | 5.2% |
| hsCRP | 4.0 | 3.0 | 0.6 |
Protocol: Tirzepatide 15mg/wk, resistance training 3x/wk, protein 1.2g/kg/day.